Medtronic, Inc. (MDT) Reports In-Line Q3 EPS of 84c; Reaffirms FY12 Sales Outlook
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $93.35 +1.14%
EPS Growth %: +10.3%
Financial Fact:
Diluted - weighted average shares outstanding: 995.8M
Today's EPS Names:
BTTX, VAXX, ELYS, More
EPS Growth %: +10.3%
Financial Fact:
Diluted - weighted average shares outstanding: 995.8M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q3 EPS of $0.84, in-line with the analyst estimate of $0.84. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $3.99 billion.
Reaffirms its FY12 sales guidance, sees EPS of $3.44-$3.47.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Reaffirms its FY12 sales guidance, sees EPS of $3.44-$3.47.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
